Background: Mycosis fungoides (MF) is histologically characterized by an accumulation of T lymphocytes (T cells) in both epidermis and dermis. However, the mechanism of the formation of Pautrier’s microabscess or the maintenance of the epidermal T cells has not yet been clarified. Objective: The rate of proliferation of these T cells was investigated. Methods: The formalin-fixed, paraffin-embedded sections from 9 cases of patch/plaque stage MF were immunostained with proliferating cell nuclear antigen (PCNA). Results: The PCNA-positive T cell nuclei were found both in the epidermis (including Pautrier’s microabscesses) and dermis in all the specimens. The mean PCNA indices of the T cells were 20.2 ± 10.6% (mean ± SD) within the epidermis and 16.8 ± 6.5% in the dermis, which was not statistically significantly different (p > 0.05). The ratio of the PCNA index between the epidermis and dermis was 1.3 ± 0.6, which was not apparently correlated with the duration of the disease (8.4 ± 5.1 years). Conclusion: These findings suggested that in situ proliferation might contribute to the epidermal T cell population resulting in the formation of Pautrier’s microabscesses and an increase in dermal T cell volume during the course of the disease.

Keywords:
Proliferative activity, Proliferating cell nuclear antigen, Mycosis fungoides, T lymphocytes, Epidermis/dermis
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.